CINDY MAN GING QUINTERO: Open Payments
NPI 1487434791 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 39 payments from 17 companies in 2025. Trend: 2023 $19 · 2024 $493 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $254 |
| Novo Nordisk Inc | 6 | $181 |
| Amgen Inc. | 3 | $70 |
| Radius Health, Inc. | 2 | $53 |
| Ascendis Pharma Endocrinology Inc | 2 | $45 |
| Corcept Therapeutics | 2 | $42 |
| Dexcom, Inc. | 2 | $36 |
| Abbott Laboratories | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 1 | $34 |
| Insulet Corporation | 1 | $29 |
Products named: Ozempic, ZEPBOUND, MOUNJARO, TEPEZZA, Tymlos, Yorvipath, Korlym, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
